Primary Stability and Peri-implant Outcomes of Short Implants in Post-extraction Single-tooth Sites

January 23, 2026 updated by: Giuseppe D'Albis, University of Bari Aldo Moro

Primary Stability and Peri-implant Outcomes of Short Implants in Post-extraction Single-tooth Sites: a Randomized Controlled Trial.

The placement of short implants in post-extraction sockets is a valuable option when residual bone height is limited, minimizing morbidity and treatment time. The management of the peri-implant gap and soft tissues may influence primary stability, hard/soft tissue remodeling, and implant success.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age ≥18 years.
  • Single-tooth post-extraction sites requiring immediate implant placement in posterior regions (premolars/molars) or selected anterior sites.
  • Planned short implant (≤7-8 mm length, 3.5-5.0 mm diameter).
  • Adequate oral hygiene, no active periodontal disease.
  • Written informed consent.

Exclusion Criteria:

  • Heavy smoking (>20 cigarettes/day).

    • Uncontrolled diabetes or systemic conditions affecting bone healing.
    • Current bisphosphonate/antiresorptive therapy.
    • Immunosuppression, pregnancy.
    • Poor oral hygiene or acute infection at site.
    • Severe bone dehiscence preventing primary stability.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1
Socket grafting with a fully resorbable synthetic biomaterial (β-tricalcium phosphate + calcium sulfate).

Two widely used approaches include:

  1. Socket grafting with a fully resorbable synthetic biomaterial (β-tricalcium phosphate + calcium sulfate).
  2. Socket grafting with a xenograft and a custom Sealing Socket Abutment (SSA) with a concave emergence profile.

No randomized controlled trials have yet compared these protocols with integrated outcomes including resonance frequency analysis, peri-implant health indices, radiographic bone level changes, and digital intraoral scanning (IOS)-based morphometric analysis.

Active Comparator: Group 2
Socket grafting with a xenograft and a custom Sealing Socket Abutment with a concave emergence profile.

Two widely used approaches include:

  1. Socket grafting with a fully resorbable synthetic biomaterial (β-tricalcium phosphate + calcium sulfate).
  2. Socket grafting with a xenograft and a custom Sealing Socket Abutment (SSA) with a concave emergence profile.

No randomized controlled trials have yet compared these protocols with integrated outcomes including resonance frequency analysis, peri-implant health indices, radiographic bone level changes, and digital intraoral scanning (IOS)-based morphometric analysis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary stability
Time Frame: 1 month
To compare the primary stability (ISQ values at implant insertion) of short implants placed in post-extraction sockets using the two grafting protocols.
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Indices
Time Frame: 12 months
To assess peri-implant health indices (PD)
12 months
Clinical Indices
Time Frame: 12 month
To assess peri-implant health indices (BoP)
12 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Giuseppe D'Albis, Dr, University of Bari Aldo Moro
  • Study Chair: Saverio Capodiferro, Prof, University of Bari Aldo Moro

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

August 10, 2026

Study Registration Dates

First Submitted

September 8, 2025

First Submitted That Met QC Criteria

September 16, 2025

First Posted (Actual)

September 17, 2025

Study Record Updates

Last Update Posted (Actual)

January 27, 2026

Last Update Submitted That Met QC Criteria

January 23, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tooth Loss

Clinical Trials on Insertion of implants in post-extraction tooth

Subscribe